Aravis Ventures

Aravis Ventures, headquartered in Zurich, Switzerland, is a well-established private equity firm with a specialized focus on two distinct, yet complementary, sectors: sustainable infrastructure, primarily renewable energy, and life sciences. Since its inception, Aravis has cultivated a strong reputation for identifying and nurturing high-growth opportunities within these critical industries. The firm's strategic approach involves managing dedicated funds for each sector, allowing for deep expertise and tailored investment strategies.

In the renewable energy sector, Aravis targets equity investments in a diverse range of infrastructure projects across Europe, including solar, wind, hydro, geothermal, and biomass. The firm has successfully raised and deployed significant capital through its series of energy funds. For instance, its Aravis Energy III fund closed at EUR 250 million, demonstrating substantial commitment to the clean energy transition. These investments typically range from EUR 10 million to EUR 50 million per project, supporting large-scale developments that contribute to sustainable energy supply.

Concurrently, Aravis maintains a robust presence in the life sciences sector, providing equity financing to private biotechnology, pharmaceutical, and medical technology companies. Their geographic scope for life sciences extends to both Europe and North America, reflecting a global outlook on innovation in healthcare. The firm's dedication to this area is exemplified by its Aravis Life Sciences III fund, which successfully closed at CHF 200 million. Investments in this sector typically fall within the range of CHF 5 million to CHF 25 million per company, supporting early to mid-stage growth.

Considering both investment verticals, Aravis Ventures' typical first cheque sizes vary significantly based on the sector. For life sciences companies, the firm's initial investments can be as low as approximately $5.6 million (CHF 5 million), while large-scale renewable energy projects can command initial equity commitments of up to approximately $54 million (EUR 50 million). This broad range underscores Aravis's flexibility and capacity to deploy capital across different stages and scales within its specialized domains, consistently seeking to back ventures that promise both financial returns and positive societal impact.